Conditions: Hypercholesterolemia
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 151
Healthy volunteers: no

Brief summary:
Evaluate the safety of the long-term (1 year) coadministration of ezetimibe and simvastatin in patients with hypercholesterolemia who have not reached low density lipoprotein (LDL)-cholesterol target with 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors.

Detailed description:

Arms:
arm 1: Ezetimibe 10 mg + Simvastatin 20 mg

Interventions: intervention 1: Ezetimibe intervention 2: Simvastatin
Intervention descriptions: intervention 1: Ezetimibe 10 mg once daily intervention 2: Simvastatin 20 mg daily

Protocol document: